Essays about: "Merger and Acquisition in Pharmaceutical"

Showing result 1 - 5 of 8 essays containing the words Merger and Acquisition in Pharmaceutical.

  1. 1. Capturing killer acquisitions in the digital sector: Article 102, EU Merger Control and Commission’s approach

    University essay from Lunds universitet/Juridiska institutionen; Lunds universitet/Juridiska fakulteten

    Author : Markus Pentti Ilari Porkka; [2022]
    Keywords : Killer acquisitions; GAFAM; digital sector; digital markets; kill zone; Article 102; potential competitor; Law and Political Science;

    Abstract : The ‘killer acquisition’ -phenomenon has been a subject of heated discussion for past several years. It usually describes as a situation where the target company, commonly a start-up, is acquired by an incumbent and its innovation products are discontinued. READ MORE

  3. 2. The impact on Key Performance Indicators after Merger & Acquisition

    University essay from Umeå universitet/Företagsekonomi

    Author : Mian Haroon Arshad; Faisal Shehzad; [2021]
    Keywords : ;

    Abstract : Merger and Acquisition is an important activity for the companies involved in it. They are a method for the acquiring company to increase not only its market presence, but it also helps to increase share holders value and diversifies the product portfolio. READ MORE

  4. 3. Killer acquisitions and European merger control in the digital era

    University essay from Lunds universitet/Institutionen för handelsrätt

    Author : Aline Alves Fulgencio; [2021]
    Keywords : killer acquisitions; GAFAM; EU mergers regulation; US antitrust law; Law and Political Science;

    Abstract : The Big Tech companies, more precisely the five American giants: Google, Apple, Facebook, Amazon and Microsoft, have been performing a massive number of startup acquisitions and strengthening their dominant position in the market. In an economical study about mergers in the pharmaceutical sector the term killer acquisition was firstly adopted to define a transaction in which an incumbent, after acquiring a innovative target, terminates the development of the target’s innovations in order to prevent a future competitor. READ MORE

  5. 4. The effect of acquired company EBITDA on the deal value within M&A context : A study on the Pharmaceutical sector

    University essay from Högskolan i Jönköping/IHH, Nationalekonomi

    Author : Armand-Valeriu Perianu; Constantin Copãceanu; [2019]
    Keywords : Merger; Acquisition; Pharmaceutical; EBITDA multiple; Deal value; Synergy;

    Abstract : This thesis examines the impact of the valuation multiple ‘earnings before interest, taxes, depreciation and amortization’ (EBITDA) on the ‘merger and acquisition’ (M&A) activity and deal value. For small firms, mergers are primarily an exit strategy for firms in financial trouble, as indicated by few marketed products and low cash-sales ratios. READ MORE

  6. 5. Effect of M&A announcement on acquirer stock prices in the Pharmaceutical sector and the role of bid premium

    University essay from Uppsala universitet/Företagsekonomiska institutionen

    Author : Pulkesh Mishra; [2018]
    Keywords : Pharmaceutical sector; M A; bid premium; Cumulative abnormal returns CAR ;

    Abstract : A majority of previous studies reveal evidences of negative or no abnormal returns for the bidder/acquirer firm upon the announcement of a merger or acquisition (M&A). Additionally, these studies stress on the importance of ‘bid premium’ announced as a key factor influencing acquirer returns post M&A announcement. READ MORE